A prospective study shows PSMA PET/CT-guided targeted biopsy detects clinically significant prostate cancer in 37 percent of ...
A new study shows that an interpretable AI model fusing 18F-PSMA-1007 PET/CT and multiparametric MRI can predict prostate ...
Mechanistically, 18F-FET uptake reflects heightened LAT1/LAT2 amino-acid transport in tumor, typically yielding higher ...
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men with ...
Health and Me on MSN
PET-CT in colon cancer: When can it help?
PET-CT is not routinely needed for every colon cancer patient, but it can help in selected cases by identifying suspected ...
The U.S. Food and Drug Administration has granted Fast Track designation to Telix Pharmaceuticals’ BiPASS program, which is evaluating gallium-68 (68Ga) PSMA-PET combined with MRI before prostate ...
Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces that the United States (U.S.) Food and Drug Administration (FDA) has granted Fast Track designation for the Company's ...
PSMA PET/CT-targeted biopsy detects more clinically significant prostate cancer than systematic biopsy alone in men whose MRI ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results